A blocking peptide containing 17 amino acids near the carboxy terminus of human APG7.
Points forts
Source
Synthetic
(Accession #: NP_006386) The ATG7 Blocking Peptide has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-049477 |
|---|
| Réf. fabricant | 18279705 |
|---|
| Gene ID (Entrez) | 10533 |
|---|
| Espèces | Human |
|---|
| Contenu et stockage | Store at -20 C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
|---|
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP1-76649. For Further Blocking Peptide Related Protocol, Click Here . |
|---|
| Alias de gène | APG7 autophagy 7-like (S. cerevisiae), APG7L, APG7-LIKE, ATG12-activating enzyme E1 ATG7, ATG7 autophagy related 7 homolog (S. cerevisiae), Autophagy-related protein 7, DKFZp434N0735, GSA7, hAGP7, ubiquitin activating enzyme E1-like protein, Ubiquitin-activating enzyme E1-like protein, ubiquitin-like modifier-activating enzyme ATG7 |
|---|
| Symbole de gène(s) | ATG7 |
|---|
| Type de produit | ATG7 |
|---|
| Quantité | 0.05 mg |
|---|
| État réglementaire | RUO - research use only |
|---|
| Source | Synthetic |
|---|
| Consigne | 17 amino acids near the carboxy terminus of human APG7 |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
